These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 8738955)

  • 21. Correlation between histopathological findings of the liver and IgA class antibodies to 2-oxo-acid dehydrogenase complex in primary biliary cirrhosis.
    Masuda J; Omagari K; Ohba K; Hazama H; Kadokawa Y; Kinoshita H; Hayashida K; Hayashida K; Ishibashi H; Nakanuma Y; Kohno S
    Dig Dis Sci; 2003 May; 48(5):932-8. PubMed ID: 12772793
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Detection of anti-mitochondrial 2-oxoacid dehydrogenase complex subunit's antibodies for the diagnosis of Primary Biliary Cholangitis.
    Poyatos E; Morandeira F; Climent J; Mas V; Castellote J; Bas J
    Clin Immunol; 2024 Nov; 268():108749. PubMed ID: 33945872
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The immunopathogenesis of primary biliary cirrhosis.
    Quaranta S; Van de Water J; Ishibashi H; Rosina F; Coppel R; Uibo R; Gershwin ME
    Hepatogastroenterology; 1999; 46(30):3041-7. PubMed ID: 10626157
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Identification and precursor frequency analysis of a common T cell epitope motif in mitochondrial autoantigens in primary biliary cirrhosis.
    Shimoda S; Van de Water J; Ansari A; Nakamura M; Ishibashi H; Coppel RL; Lake J; Keeffe EB; Roche TE; Gershwin ME
    J Clin Invest; 1998 Nov; 102(10):1831-40. PubMed ID: 9819369
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Biochemistry and autoimmune response to the 2-oxoacid dehydrogenase complexes in primary biliary cirrhosis.
    Bassendine MF; Jones DE; Yeaman SJ
    Semin Liver Dis; 1997 Feb; 17(1):49-60. PubMed ID: 9089910
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Primary biliary cirrhosis. Inhibition of pyruvate dehydrogenase complex activity by autoantibodies specific for E1 alpha, a non-lipoic acid containing mitochondrial enzyme.
    Fregeau DR; Roche TE; Davis PA; Coppel R; Gershwin ME
    J Immunol; 1990 Mar; 144(5):1671-6. PubMed ID: 2106552
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Clinical significance of positive immunoblotting but negative immunofluorescence for antimitochondrial antibodies in patients with liver diseases other than primary biliary cirrhosis.
    Masuda J; Omagar K; Miyakawa H; Hazama H; Ohba K; Kinoshita H; Matsuo I; Isomoto H; Murata I; Kohno S
    Autoimmunity; 2002 Mar; 35(2):135-41. PubMed ID: 12071436
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Environment and primary biliary cirrhosis: electrophilic drugs and the induction of AMA.
    Leung PS; Wang J; Naiyanetr P; Kenny TP; Lam KS; Kurth MJ; Gershwin ME
    J Autoimmun; 2013 Mar; 41():79-86. PubMed ID: 23352659
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Primary biliary cirrhosis is characterized by IgG3 antibodies cross-reactive with the major mitochondrial autoepitope and its Lactobacillus mimic.
    Bogdanos DP; Baum H; Okamoto M; Montalto P; Sharma UC; Rigopoulou EI; Vlachogiannakos J; Ma Y; Burroughs AK; Vergani D
    Hepatology; 2005 Aug; 42(2):458-65. PubMed ID: 16025495
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Heterogeneous response of antimitochondrial autoantibodies and bile duct apical staining monoclonal antibodies to pyruvate dehydrogenase complex E2: the molecule versus the mimic.
    Migliaccio C; Van de Water J; Ansari AA; Kaplan MM; Coppel RL; Lam KS; Thompson RK; Stevenson F; Gershwin ME
    Hepatology; 2001 Apr; 33(4):792-801. PubMed ID: 11283841
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Characterization of recombinant monoclonal IgA anti-PDC-E2 autoantibodies derived from patients with PBC.
    Fukushima N; Nalbandian G; Van De Water J; White K; Ansari AA; Leung P; Kenny T; Kamita SG; Hammock BD; Coppel RL; Stevenson F; Ishibashi H; Gershwin ME
    Hepatology; 2002 Dec; 36(6):1383-92. PubMed ID: 12447863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Sera from patients with tuberculosis recognize the M2a-epitope (E2-subunit of pyruvate dehydrogenase) specific for primary biliary cirrhosis.
    Klein R; Wiebel M; Engelhart S; Berg PA
    Clin Exp Immunol; 1993 May; 92(2):308-16. PubMed ID: 7683589
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Demonstration of PDC-E1 subunits as major antigens in the complement-fixing fraction M4 and re-evaluation of PDC-E1-specific antibodies in PBC patients.
    Berg CP; Stein GM; Klein R; Pascu M; Berg T; Kammer W; Priemer M; Nordheim A; Schulze-Osthoff K; Gregor M; Wesselborg S; Berg PA
    Liver Int; 2006 Sep; 26(7):846-55. PubMed ID: 16911468
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Differing epitope selection of experimentally-induced and natural antibodies to a disease-specific autoantigen, the E2 subunit of pyruvate dehydrogenase complex (PDC-E2).
    Rowley MJ; Maeda T; Mackay IR; Loveland BE; McMullen GL; Tribbick G; Bernard CC
    Int Immunol; 1992 Nov; 4(11):1245-53. PubMed ID: 1282029
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunization with a xenobiotic 6-bromohexanoate bovine serum albumin conjugate induces antimitochondrial antibodies.
    Leung PS; Quan C; Park O; Van de Water J; Kurth MJ; Nantz MH; Ansari AA; Coppel RL; Lam KS; Gershwin ME
    J Immunol; 2003 May; 170(10):5326-32. PubMed ID: 12734383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope.
    Leung PS; Chuang DT; Wynn RM; Cha S; Danner DJ; Ansari A; Coppel RL; Gershwin ME
    Hepatology; 1995 Aug; 22(2):505-13. PubMed ID: 7543435
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Molecular mimicry in primary biliary cirrhosis. Evidence for biliary epithelial expression of a molecule cross-reactive with pyruvate dehydrogenase complex-E2.
    Van de Water J; Turchany J; Leung PS; Lake J; Munoz S; Surh CD; Coppel R; Ansari A; Nakanuma Y; Gershwin ME
    J Clin Invest; 1993 Jun; 91(6):2653-64. PubMed ID: 8514873
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Immunopathogenesis of primary biliary cirrhosis.
    Nishio A; Keeffe EB; Gershwin ME
    Semin Liver Dis; 2002 Aug; 22(3):291-302. PubMed ID: 12360422
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heterogeneity of autoreactive T cell clones specific for the E2 component of the pyruvate dehydrogenase complex in primary biliary cirrhosis.
    Van de Water J; Ansari A; Prindiville T; Coppel RL; Ricalton N; Kotzin BL; Liu S; Roche TE; Krams SM; Munoz S; Gershwin ME
    J Exp Med; 1995 Feb; 181(2):723-33. PubMed ID: 7836925
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The clinical significance of IgA antimitochondrial antibodies in sera and saliva in primary biliary cirrhosis.
    Tanaka A; Nezu S; Uegaki S; Mikami M; Okuyama S; Kawamura N; Aiso M; Gershwin ME; Takahashi S; Selmi C; Takikawa H
    Ann N Y Acad Sci; 2007 Jun; 1107():259-70. PubMed ID: 17804554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.